NEOLISE Recovery Protocol Faces Uncertain FDA Status
News related to:NEOLISE Recovery · 2 min read
NEOLISE Recovery, a peptide protocol marketed for recovery support, has gained attention as more consumers explore provider-guided options in 2026. The brand offers a compounded BPC-157/TB-500 protocol through an independent telehealth process. However, the product’s current status and pricing remain subjects of scrutiny.
According to NEOLISE, the protocol is administered through a network of independent licensed providers and a compounding pharmacy. The intake process typically involves filling out an online questionnaire, with some states requiring a video visit. The cost of the NEOLISE Recovery plan ranges from $897 to $1,614 upfront. The protocol consists of a single pre-mixed injectable vial of BPC-157 and TB-500, which are shipped cold with syringes and alcohol prep pads.
The FDA status of BPC-157 and TB-500 is significant. In April 2026, both substances were removed from the FDA's Category 2 interim-policy list. However, this action did not result in FDA approval or clearance. In July 2026, the FDA's Pharmacy Compounding Advisory Committee (PCAC) voted to recommend adding both BPC-157 and TB-500 to the Section 503A Bulks List, a non-binding recommendation. As of September 2026, neither substance has been officially placed on this list, and no final FDA rule has been issued.
The effectiveness of the protocol is backed by preclinical research, including studies on tendon, ligament, muscle, bone, and gut health in animal models. However, controlled human trials remain limited. NEOLISE markets the protocol under the "Wolverine effect" nickname, which is not an FDA-approved classification or proof of effectiveness.
Consumers considering the NEOLISE Recovery protocol should verify several details before committing. These include confirming the current FDA status, the specific pharmacy and provider involved, and the dosing schedule. The brand states that the exact concentration and dosing schedule can vary by pharmacy and individual prescription, so buyers should rely on the individualized instructions supplied directly by the prescriber and dispensing pharmacy.
In summary, while NEOLISE Recovery offers a promising recovery protocol, consumers must be cautious and thoroughly research the product’s FDA status, provider process, and pricing before making a decision.